Search images on Google Product Monograph
Active Ingredients:
- insulin glargine, 100 UNIT/ML
- lixisenatide, 33 MCG/ML
DIN: 02478293
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Schedule: Prescription
Company: SANOFI-AVENTIS CANADA INC – official site
ATC:
- A10 - DRUGS USED IN DIABETES (ATC, WHO, Wiki)
- A10A - INSULINS AND ANALOGUES (ATC, WHO)
- A10AE - Insulins and analogues for injection, long-acting (ATC, WHO)
- A10AE54 - INSULIN GLARGINE AND LIXISENATIDE (WHO)
External Links for Soliqua:
Search on Google
- Soliqua side effects
- Soliqua dosage
- insulin glargine side effects
- insulin glargine dosage
- lixisenatide side effects
- lixisenatide dosage
Sanofi-Aventis Canada Inc
Go to Sanofi-Aventis website to see drug product details. Sometimes you can find soliqua photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.